• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Secukinumab Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759575

Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment,of moderate to severe plaque psoriasis. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Secukinumab, Inhibitor
Full Product Name
Secukinumab
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
151000
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
CAS Number
875356-43-7
Target & IC50
IL17A

Product References and Citations for Secukinumab, inhibitor

Frieder J, et al.Secukinumab: a review of the anti-IL-17A biologic for the treatment,of psoriasis. Ther Adv Chronic Dis. 2018 Jan;9(1):5-21.
Frieder J, et al.Secukinumab: a review of the anti-IL-17A biologic for the treatment,of psoriasis. Ther Adv Chronic Dis. 2018 Jan;9(1):5-21.

Other Notes

Small volumes of Secukinumab, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Secukinumab purchase

MBS5759575 is an inhibitor targeting Secukinumab.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000